NCT07110909 is a NA clinical trial of HPV Education in Human Papilloma Virus (HPV), sponsored by Gizem ÇITAK.

Who is sponsoring NCT07110909?

NCT07110909 is sponsored by Gizem ÇITAK.

What drugs are being tested in NCT07110909?

Interventions in NCT07110909: HPV Education.

What condition does NCT07110909 study?

NCT07110909 studies Human Papilloma Virus (HPV).

Is NCT07110909 still recruiting?

NCT07110909 is currently completed. Last updated 8 August 2025.

Last reviewed 2025-08-08 · How we verify

NCT07110909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of HPV Education on Knowledge, Awareness, and Concern

Completed NA Last updated 8 August 2025

What this trial tests

NA trial testing HPV Education in Human Papilloma Virus (HPV) in 103 participants. Completed in 2 April 2025.

Timeline

1 January 2025

Primary endpoint
1 April 2025

2 April 2025

Quick facts

Lead sponsor	Gizem ÇITAK
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	103
Start date	1 January 2025
Primary completion	1 April 2025
Estimated completion	2 April 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

HPV Education

Conditions studied

Human Papilloma Virus (HPV) — all drugs for Human Papilloma Virus (HPV) →

Sponsor

Gizem ÇITAK

Who can join

Adults 18 to 49, female only, with Human Papilloma Virus (HPV). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled study is being conducted between January and April 2025 at a Family Health Center in the Black Sea Region with 103 women (intervention group: 50, control group: 53) selected via randomizer.org. Participants complete pre-tests, receive HPV and cervical cancer prevention education, and take post-tests to evaluate the impact of the intervention. Keywords: HPV, education, knowledge, awareness, midwife.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Human Papilloma Virus (HPV)

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07214584 — Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Respons · recruiting

Other Gizem ÇITAK trials

Trials by the same sponsor.

NCT07154459 — Breastfeeding Education and Prenatal & Paternal Attachment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07110909 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gizem ÇITAK
Last refreshed: 8 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07110909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing